Quarry LP
Long book
$483.2M
Q1 2026
Positions
1347
Top-10 weight
32%
concentration
Last quarter
+7.4%
SPY +14.8%
Turnover
59%
of book per quarter
Strategy in plain words
auto-generated from filingsQuarry LP is a mechanically diversified allocator, running a $483.2M US long book across 1347 positions.
The portfolio is moderately concentrated (top 10 ≈ 32% of the book). Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: CORNERSTONE STRATEGIC INVEST, CORNERSTONE TOTAL RETURN, CHART INDUSTRIES INC, LEARWATER ANALYTICS HLDGS I, NORFOLK SOUTHERN CORP.
Over the last 9 quarters its long book ran on average 2.5pp per quarter behind the S&P 500, beating the index in 2 of 9 quarters. Its holdings are mechanical (indexing / client flows), so position changes carry no stock-picking signal.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-0.7%
Q2 2024
+4.1%
Q3 2024
-0.7%
Q4 2024
-10.1%
Q1 2025
+7.5%
Q2 2025
+4.6%
Q3 2025
+8.6%
Q4 2025
-3.1%
Q1 2026
+7.4%
Sector allocation
Financials 28%
Industrials 18%
Healthcare 12%
Technology 12%
Other 10%
Communications 7%
Utilities 4%
Services media 4%
Long book by quarter
What does Quarry LP own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| GTLS CHART INDUSTRIES INC | Industrials | 80.8K | $16.7M | 3.5% | +138.8% |
| NSC NORFOLK SOUTHERN CORP | Industrials | 55.4K | $15.9M | 3.3% | +26.6% |
| WBD WARNER BROS DISCOVERY INC | Communications | 539.6K | $14.8M | 3.1% | +25255.2% |
| BCAR D. BORAL ARC ACQUISIT - CL A | Technology | 1.3M | $13.2M | 2.7% | New |
| PEN PENUMBRA INC | Healthcare | 39.3K | $12.9M | 2.7% | New |
| CAEP CANTOR EQUITY PARTNERS III-A | — | 1.1M | $11.4M | 2.4% | +33.3% |
| KVUE KENVUE INC | Other | 564.8K | $9.7M | 2.0% | +12763.1% |
| IPCX INFLECTION POINT ACQUISITI-A | Financials | 909.1K | $9.3M | 1.9% | +27.3% |
| QRVO QORVO INC | Technology | 93.5K | $7.2M | 1.5% | +13736.1% |
| RVMD REVOLUTION MEDICINES INC | Healthcare | 59.3K | $5.8M | 1.2% | New |
| GSRF GSR IV ACQUISITION CORP-CL A | Financials | 562.4K | $5.6M | 1.2% | New |
| UNF UNIFIRST CORP/MA | Services media | 21.4K | $5.4M | 1.1% | +533675.0% |
| SOUL SOULPOWER ACQUISITION CO-A | Financials | 402.7K | $4.1M | 0.9% | New |
| CEPO CANTOR EQUITY PARTNERS I-A | Financials | 358.5K | $3.8M | 0.8% | +42.8% |
| TXNM TXNM ENERGY INC | Utilities | 63.3K | $3.7M | 0.8% | -61.0% |
| XRPN ARMADA ACQUISITION -CLASS A | Financials | 307.1K | $3.2M | 0.7% | +108.3% |
| ATII ARCHIMEDES TECH SPAC PARTNER | Financials | 285.0K | $3.0M | 0.6% | New |
| ECHO ECHOSTAR CORP-A | Communications | 24.7K | $2.9M | 0.6% | -22.1% |
| DMAA DRUGS MADE IN AMERICA ACQUIS | Financials | 266.6K | $2.8M | 0.6% | Held |
| NPAC NEW PROVIDENCE ACQUISITION-A | Financials | 250.0K | $2.6M | 0.5% | New |
| MCGA YORKVILLE ACQUISITION CORP-A | Financials | 252.1K | $2.5M | 0.5% | New |
| BACC BLUE ACQUISITION CORP-CL A | Financials | 228.0K | $2.3M | 0.5% | New |
| ANSC AGRICULTURE & NATURAL SOLUTI | Financials | 194.7K | $2.2M | 0.5% | -60.6% |
| AACB ARTIUS II ACQUISITION INC-A | Financials | 210.5K | $2.2M | 0.5% | +90.5% |
| KVAC KEEN VISION ACQUISITION CORP | Financials | 149.5K | $1.8M | 0.4% | -40.5% |
| FGMC FG MERGER II CORP | Financials | 177.6K | $1.8M | 0.4% | Held |
| EURK EUREKA ACQUISITION CORP | Industrials | 155.4K | $1.8M | 0.4% | Held |
| LPAA LAUNCH ONE ACQUISITION CORP | Financials | 150.0K | $1.6M | 0.3% | Held |
| MBAV M3-BRIGADE ACQUISITION V-A | Financials | 146.3K | $1.6M | 0.3% | +7336.3% |
| DRDB ROMAN DBDR ACQUISITION CORP | Financials | 150.0K | $1.6M | 0.3% | +199.8% |
| FVN FUTURE VISION II ACQUISITION | Technology | 145.0K | $1.6M | 0.3% | Held |
| SBXD SILVERBOX CORP IV-A | Financials | 141.6K | $1.5M | 0.3% | Held |
| FSHP FLAG SHIP ACQUISITION CORP | Financials | 130.0K | $1.4M | 0.3% | Held |
| CEPV CANTOR EQUITY PARTNERS-CL A | Financials | 125.0K | $1.3M | 0.3% | Held |
| BEAG BOLD EAGLE ACQUISITION COR-A | Financials | 107.7K | $1.1M | 0.2% | -8.5% |
| SIMA SIM ACQUISITION CORP I-A | Financials | 100.0K | $1.1M | 0.2% | Held |
| KFII K&F GROWTH ACQUISITION COR-A | Financials | 100.0K | $1.0M | 0.2% | New |
| TMS TEAMSHARES INC | Consumer discretionary | 100.0K | $1.0M | 0.2% | +100.0% |
| JENA JENA ACQUISITION CORP II - A | Financials | 100.0K | $1.0M | 0.2% | Held |
| HLXC HELIX ACQUISITION CORP-CL A | Financials | 100.0K | $1.0M | 0.2% | New |
| RNA ATRIUM THERAPEUTICS INC | Healthcare | 66.7K | $891K | 0.2% | New |
| PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 2.8K | $886K | 0.2% | -31.3% |
| AXSM AXSOME THERAPEUTICS INC | Healthcare | 5.0K | $845K | 0.2% | +24900.0% |
| CHPG CHAMPIONSGATE ACQUISITIO-A | Financials | 80.0K | $820K | 0.2% | Held |
| PRTH PRIORITY TECHNOLOGY HOLDINGS | Services media | 169.8K | $802K | 0.2% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 15, 2026 | 1364 | $557.5M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 13, 2026 | 2091 | $639.2M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 2137 | $456.1M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 1694 | $470.0M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 1594 | $461.1M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 1587 | $712.2M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 1585 | $397.9M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR/ANEW HOLDINGS | Aug 16, 2024 | 1766 | $347.7M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 1755 | $349.1M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 15, 2024 | 1611 | $523.3M | canonical | SEC ↗ |
Similar funds
VANGUARD CAPITAL MANAGEMENT LLCVANGUARD PORTFOLIO MANAGEMENT LLCPRICE T ROWE ASSOCIATES INC /MD/Bank of New York Mellon CorpLegal & General Group PlcVANGUARD FIDUCIARY TRUST CONuveen, LLCAmundiJANUS HENDERSON GROUP PLCAMERICAN CENTURY COMPANIES INCPRINCIPAL FINANCIAL GROUP INCVanguard Global Advisers, LLC